Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2012
11/08/2012WO2012150130A1 A topical formulation comprising a corticosteroid as active ingredient
11/08/2012WO2012121971A3 Locally released growth factors to mediate motor recovery after stroke
11/08/2012WO2012120364A3 Novel immediate release film coating composition and preparation process thereof
11/08/2012WO2012078647A3 Chemical composition to detect and treat amyloid in a patient's brain and retina
11/08/2012WO2012017119A3 Non -viral vectors for gene therapy
11/08/2012US20120283338 Sweetener compositions and methods of making the same
11/08/2012US20120283337 Inorganic porous particles with stabilized micropores
11/08/2012US20120283253 Semi-Solid Delivery Vehicle and Pharmaceutical Compositions
11/08/2012US20120283233 Carrier composition
11/08/2012US20120283218 MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
11/08/2012US20120283214 Cyclodextrin-based polymers for therapeutics delivery
11/08/2012US20120283205 Compositions and methods of delivery of pharmacological agents
11/08/2012US20120283195 Glycopeptide phosphonate derivatives
11/08/2012US20120283187 Controlled release composition and method of producing the same
11/08/2012US20120282323 Dry Liposomal PVP-iodine Compositions
11/08/2012US20120282320 Hemostatic dressing
11/08/2012US20120282317 Medicated popsicle system
11/08/2012US20120282312 Active ingredient delivery system
11/08/2012US20120282307 Gastric retained gabapentin dosage form
11/08/2012US20120282306 Polymer-agent conjugates, particles, compositions, and related methods of use
11/08/2012US20120282302 Biomaterial composite composition and method of use
11/08/2012US20120282299 Coatings comprising bis-(alpha-amino-diol-diester) containing polyesteramide
11/08/2012US20120282270 Formulation of human antibodies for treating tnf-alpha associated disorders
11/08/2012US20120282186 Templated nanoconjugates
11/08/2012CA2835109A1 Finite fully addressable nucleic acid nanostructures as nanocarriers for delivery of pharmaceuticals
11/08/2012CA2835062A1 Transdermal compositions of ibuprofen and methods of use thereof
11/08/2012CA2835013A1 Eye drops for treatment of conjunctivochalasis
11/08/2012CA2834900A1 Formulation for anti-.alpha.4.beta.7 antibody
11/08/2012CA2834885A1 Composition and method for treatment of diabetes
11/08/2012CA2834867A1 Formulation for anti-.alpha.4.beta.7 antibody
11/08/2012CA2834788A1 Cochleate compositions and methods of making and using same
11/08/2012CA2834301A1 Treatment of psoriasis
11/08/2012CA2834128A1 Peptide oligonucleotide conjugates
11/08/2012CA2831572A1 Ultrafiltration concentration of allotype selected antibodies for small-volume administration
11/08/2012CA2831340A1 Excipient compatibility with ezatiostat
11/07/2012EP2520600A2 Macromolecule for delivering protein, polypeptide or peptide drugs and a production method for the same, and a slow release composition for protein, polypeptide or peptide drugs and a production method for the same
11/07/2012EP2520312A1 A process for manufacturing a delivery system for active components as part of an edible composition
11/07/2012EP2520299A1 Solid pharmaceutical composition for oral administration
11/07/2012EP2520289A1 Norethisterone-containing patch
11/07/2012EP2520281A2 Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof
11/07/2012EP2520279A1 Thermoreversible gel pharamaceutical compositions for odontoiatric use
11/07/2012EP2520165A1 Medium, solutions and methods for the washing, culturing and storage of white blood cells
11/07/2012EP2519546A1 Method for synthesizing calixarene and/or cyclodextrin copolymers, terpolymers and tetrapolymers, and uses thereof
11/07/2012EP2519545A1 Method for synthesizing calixarene and/or cyclodextrin copolymers, terpolymers and tetrapolymers, and uses thereof
11/07/2012EP2519265A2 Polysaccharide immunogens conjugated to e. coli carrier proteins
11/07/2012EP2519264A1 Taste masked dosage forms of bitter tasting anti-retroviral drugs
11/07/2012EP2519263A1 Lipopeptide- and lipoprotein-conjugates and its use
11/07/2012EP2519262A2 Antibody formulation
11/07/2012EP2519261A1 Oral liquid pharmaceutical composition of nifedipine
11/07/2012EP2519226A1 Orally administrable film dosage forms containing ondansetron
11/07/2012EP2519224A1 Melt extruded thin strips containing coated pharmaceutical actives
11/07/2012EP2519217A2 Use of skin permeation and retention enhancer compound in cosmetic and pharmaceutical compositions and cosmetic and pharmaceutical products containing said compound
11/07/2012CN202516036U Drug carrier
11/07/2012CN1985827B Compound ciprofloxacin injection for animal and its preparing process
11/07/2012CN1943585B Breviscapine proliposome powder preparation
11/07/2012CN102770407A Crosslinked zwitterionic hydrogels
11/07/2012CN102770161A Conjugate with target-finding ligand and use thereof
11/07/2012CN102770160A Compatibilized electrolyte formulations
11/07/2012CN102770158A Antibody formulation
11/07/2012CN102770157A Formulations of antibody
11/07/2012CN102770152A Mucosal delivery of peptides
11/07/2012CN102770144A Additive for erythrocyte-rich solution, and container for medical purposes
11/07/2012CN102770121A Pharmaceutical composition comprising solvent mixture and a vitamin D derivative or analogue
11/07/2012CN102766634A Single-stranded deoxyribonucleic acid (ssDNA) aptamer targeting human highly metastatic hepatoma carcinoma cell and application thereof
11/07/2012CN102766540A Liquid enzyme stabilizing additive and preparation method and application thereof
11/07/2012CN102766262A Preparation method for difunctional nanoparticle carrier and preparation method for difunctional nanoparticle preparation
11/07/2012CN102766258A Resveratrol hydrophilic conjugate, its preparation method and application
11/07/2012CN102766250A Polythiophene microballs and preparation method thereof
11/07/2012CN102766228A Preparation method and application of polymeric micelle with triple responsiveness
11/07/2012CN102766220A Hydrophobic modified beta-1, 3-D-glucan and preparation method and applications thereof
11/07/2012CN102766215A Polypeptide with function of synergic targeting treatment of nasopharyngeal carcinoma, nanoparticle carrying the polypeptide and application thereof
11/07/2012CN102766066A Gel factor as well as preparation method and application thereof
11/07/2012CN102764442A Method for preparing nano particles comprising protamine and genetic material
11/07/2012CN102764437A Methoxsalen injection and preparation method thereof
11/07/2012CN102764433A Prawn white spot syndrome virus multivalent vector vaccine and application thereof
11/07/2012CN102764430A Nasal spraying mucosa immunizing vaccine composition and preparation method thereof
11/07/2012CN102764426A Scorpion venom protein polypeptide colon-targeted preparation and preparation method thereof
11/07/2012CN102764424A Drug composition of thymopentin composed of five kinds of amino acids and preparation method thereof
11/07/2012CN102764417A Chinese materia medica frostbite cream
11/07/2012CN102764413A Di Zhen granule and preparation method thereof
11/07/2012CN102764303A Preparation for safe and efficient arsenic-free pulp devitalizer and application thereof
11/07/2012CN102764301A Novel technology for preparing children's radix bupleuri/cassia twig antipyretic particles
11/07/2012CN102764281A Ointment for treating condyloma acuminatum and preparation method thereof
11/07/2012CN102764268A Acid-base neutralization solution for protecting human body from being burned by chemical substances
11/07/2012CN102764267A Carbomer cervical gel
11/07/2012CN102764264A Celecoxib solid composition with high dissolution, preparation method and application
11/07/2012CN102764261A Oral composition controlling release of trimetazidine dihydrochloride and preparation method of oral composition
11/07/2012CN102764260A Pharmaceutical composition of camptothecin derivative and preparation method thereof
11/07/2012CN102764257A Flupirtine maleate sustained release tablet
11/07/2012CN102764247A Rapidly dissolving film for delivery of an active agent
11/07/2012CN102764246A Trospium chloride controlled release capsule and preparation method thereof
11/07/2012CN102764244A Solid pharmaceutical dosage form
11/07/2012CN102764243A Aspirin pulsed release pellets, its preparation and preparation method thereof
11/07/2012CN102764242A Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient
11/07/2012CN102764241A Freeze-dried pharmaceutical composition containing gemcitabine hydrochloride
11/07/2012CN102764239A Propylthiouracil sustained release pellet
11/07/2012CN102764238A Preparation method of ribavirin effervescent granules
11/07/2012CN102764237A Oral enteric-coated pellet medicinal preparation
11/07/2012CN102764236A Matrine granules and preparation method thereof
11/07/2012CN102764234A Topotecan hydrochloride targeted liposome preparation and preparation method thereof
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 1712